Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alembic Pharma bags USFDA nod for mantle cell lymphoma drug Acalabrutinib

Ruchika Sharma19 Jan 2023 3:15 PM IST

Acalabrutinib Capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy...

India targeting global arena with high value pharma med-tech products, says Mansukh Mandaviya

Ruchika Sharma19 Jan 2023 2:15 PM IST

The minister urged the pharma and med-tech sectors to move out of their comfort zones and adopt innovation as a driving feature of their business...

Serum Institute seeks inclusion of Covovax in CoWIN portal as heterologous booster dose for adults: Sources

Ruchika Sharma19 Jan 2023 1:45 PM IST

Covovax is manufactured through technology transfer from Novavax.

Sanofi to buy Vigil Neuroscience in USD 470 million deal

Eris Lifesciences to acquire Onabet, Halobate and 7 other dermatology brands from Glenmark Pharma for over Rs 338 crore

Ruchika Sharma19 Jan 2023 11:45 AM IST

Bengaluru: Indian drugmaker Eris Lifesciences Ltd said on Tuesday it would acquire a portfolio of dermatology brands from Glenmark...

Aurobindo Pharma arm API facility gets 3 observations from USFDA

Aurobindo Pharma arm gets 2 USFDA observations for Unit I, III in Telangana

Ruchika Sharma19 Jan 2023 10:56 AM IST

Hyderabad: Aurobindo Pharma has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with 2 observations at the end of the...

CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study

Abbott gets USFDA nod for next-generation TAVI system Navitor to treat Aortic Stenosis

Ruchika Sharma18 Jan 2023 3:30 PM IST

Navitor features a unique fabric cuff (NaviSeal) to reduce or eliminate the backflow of blood around the valve frame known as paravalvular leak (PVL).

Pfizer offers up full portfolio of drugs to low income countries at non-profit prices

Ruchika Sharma18 Jan 2023 2:30 PM IST

Pfizer will now expand its offering under the Accord to include off-patent products, bringing the total offering from 23 products to around 500...

Merck set to remove cancer-causing chemical from top diabetes drugs

Ruchika Sharma18 Jan 2023 1:15 PM IST

New Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...

Strides Pharma Science Acetaminophen and Ibuprofen Tablets

Strides Pharma Science biologics arm gets USFDA EIR for Bengaluru facility

Ruchika Sharma18 Jan 2023 12:18 PM IST

Bengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm...

Blue Jet Healthcare, Innova Captab get Sebi go ahead to raise funds through IPO

Ruchika Sharma18 Jan 2023 11:15 AM IST

New Delhi: Pharmaceutical companies Innova Captab Ltd and Blue Jet Healthcare have received Sebi's go-ahead to raise funds through an initial public...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis gets European Commission nod for Pluvicto to treat progressive PSMA-positive metastatic castration-resistant prostate cancer

Ruchika Sharma17 Jan 2023 3:30 PM IST

Pluvicto is an intravenous radioligand therapy combining a targeting compound (a ligand) with a therapeutic radionuclide (a radioactive particle, in...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly, AbbVie exit UK drug pricing agreement

Ruchika Sharma17 Jan 2023 2:30 PM IST

Bengaluru: Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok